Publications list for Associate Professor Jonathon Arnold

2013 | 2012 | 2011 | 2010 | 2009 | 2008

2013

   
  • Kassem, M., Lagopoulos, J., Stait-Gardner, T., Price, W., Chohan, T., Arnold, J., Hatton, S., Bennett, M. (2013), Stress-Induced Grey Matter Loss Determined by MRI Is Primarily Due to Loss of Dendrites and Their Synapses. Molecular Neurobiology. 47(2), 645-661. [Abstract]
  • Spencer, J., Chohan, T., Karl, T., Arnold, J. (2013), Female Neuregulin 1 Heterozygous Mice Require Repeated Exposure to Δ9-Tetrahydrocannabinol to Alter Sensorimotor Gating Function. Pharmacopsychiatry. 46(7), 286-291. [Abstract]
  • Wong, A., Montebello, M., Norberg, M., Rooney, K., Lintzeris, N., Bruno, R., Booth, J., Arnold, J., McGregor, I. (2013), Exercise increases plasma THC concentrations in regular cannabis users. Drug and Alcohol Dependence. 133(2), 763-767. [Abstract]
  • Long, L., Chesworth, R., Huang, X., McGregor, I., Arnold, J., Karl, T. (2013), Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. International Journal of Neuropsychopharmacology. 16(1), 163-175. [Abstract]
  • Karl, T., Arnold, J. (2013), What does a mouse tell us about neuregulin 1-cannabis interactions?. Frontiers in Cellular Neuroscience. 7, 18. [Abstract]
  • Swift, W., Wong, A., Li, K., Arnold, J., McGregor, I. (2013), Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile. PloS One. 8(7), e70052. [Abstract]
  • Spencer, J., Darbyshire, K., Boucher, A., Kashem, M., Long, L., McGregor, I., Karl, T., Arnold, J. (2013), Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice. Frontiers in Cellular Neuroscience. 7, 15. [Abstract]

2012

   
  • Spencer, J., Darbyshire, K., Boucher, A., Arnold, J. (2012), Adolescent neuregulin 1 heterozygous mice display enhanced behavioral sensitivity to methamphetamine. Progress in Neuro-psychopharmacology & Biological Psychiatry. 39(2), 376-381. [Abstract]
  • Arnold, J., Boucher, A., Karl, T. (2012), The Yin and Yang of Cannabis-induced Psychosis: the Actions of ∆(9)-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia. Current Pharmaceutical Design. 18(32), 5113-5130. [Abstract]
  • Arnold, J., Hone, P., Holland, M., Allen, J. (2012), CB(2) and TRPV(1) receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells. Pharmacological Reports. 64(3), 751-757. [Abstract]
  • Karl, T., Cheng, D., Garner, B., Arnold, J. (2012), The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opinion on Therapeutic Targets. 16(4), 407-420. [Abstract]
  • Wong, A., Gunasekaran, N., Hancock, D., Denyer, G., Meng, L., Radford, J., McGregor, I., Arnold, J. (2012), The Major Plant-derived Cannabinoid Δ9-Tetrahydrocannabinol Promotes Hypertrophy and Macrophage Infiltration in Adipose Tissue. Hormone and Metabolic Research. 44(2), 105-113. [Abstract]
  • Long, L., Chesworth, R., Huang, X., Wong, A., Spiro, A., McGregor, I., Arnold, J., Karl, T. (2012), Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. PLoS One. 7(4), e34129. [Abstract]
  • Spiro, A., Wong, A., Boucher, A., Arnold, J. (2012), Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice. PLoS One. 7(4), e35937. [Abstract]

2011

   
  • Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L., Huang, X., Liu, K., Arnold, J., McGregor, I. (2011), Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology. 218(2), 443-57. [Abstract]
  • Boucher, A., Arnold, J., Hunt, G., Spiro, A., Spencer, J., Brown, C., McGregor, I., Bennett, M., Kassiou, M. (2011), Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test. Neuroscience. 189(2011), 170-7. [Abstract]
  • Boucher, A., Hunt, G., Micheau, J., Huang, X., McGregor, I., Karl, T., Arnold, J. (2011), The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 14, 631-43. [Abstract]
  • Sokolic, L., Long, L., Hunt, G., Arnold, J., McGregor, I. (2011), Disruptive effects of the prototypical cannabinoid Δ9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. Behavioural Pharmacology. 22(3), 191-202. [Abstract]
  • Bowen, M., Carson, D., Spiro, A., Arnold, J., McGregor, I. (2011), Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PloS One. 6(11), e27237. [Abstract]

2010

   
  • van Nieuwenhuijzen, P., Long, L., Hunt, G., Arnold, J., McGregor, I. (2010), Residual social, memory and oxytocin-related changes in rats following repeated exposure to gamma-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology. 212, 663-74. [Abstract]
  • Arnold, J., Dielenberg, R., McGregor, I. (2010), Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: Strain differences in drug-induced anxiety. Life sciences. 87(17-18), 572-8. [Abstract]
  • Carson, D., Hunt, G., Guastella, A., Barber, L., Cornish, J., Arnold, J., Boucher, A., McGregor, I. (2010), Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction biology. 15(4), 448-63. [Abstract]
  • Long, L., Chesworth, R., Arnold, J., Karl, T. (2010), A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology. 211(3), 277-289. [Abstract]

2009

   
  • Gunasekaran, N., Long, L., Dawson, B., Hansen, G., Richardson, D., Li, K., Arnold, J., McGregor, I. (2009), Reintoxication: the release of fat-stored Delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology. 158(5), 1330-1337. [Abstract]
  • Boucher, A., Vivier, L., Metna-Laurent, M., Brayda-Bruno, L., Mons, N., Arnold, J., Micheau, J. (2009), Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. Behavioural Pharmacology. 20(1), 45-55. [Abstract]

2008

   
  • Jiwane, A., Holland, A., Soundappan, S., Arnold, J. (2008), An unusual case of bilious vomiting in a neonate. Journal of Paediatrics and Child Health. 44(12), 747-749. [Abstract]
  • Holland, M., Allen, J., Arnold, J. (2008), Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1). European journal of pharmacology. 591, 128-31. [Abstract]
  • Quinn, H., Matsumoto, I., Callaghan, P., Long, L., Arnold, J., Gunasekaran, N., Thompson, M., Dawson, B., Mallet, P., Kashem, M., Matsuda-Matsumoto, H., Iwazaki, T., McGregor, I. (2008), Adolescent Rats Find Repeated Delta(9)-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 33(0), 1113-26. [Abstract]